(PharmaNewsWire.Com, May 02, 2017 ) Middle-East and Africa Clinical Trials Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 7.55% to reach USD 1.70 billion by 2021, from USD 1.18 billion in 2016.
Clinical trials are organized to collect data regarding the efficacy and safety of new device and drug development. Depending on a number of factors, trials can be quite costly. The sponsor may be a governmental organization or a biotechnology, pharmaceutical or medical device company. Certain functions essential to the trial, such as lab work and monitoring, may be directed by an outsourced partner, such as a central laboratory or a contract research organization.
Key factors which affect and thereby cause changes to the market dynamics are studied essentially and are presented in a well-known way in the report. Some of those factors are
Due to alliances between the clinical research organizations and the pharma-biotech companies Rising demand for outsourcing clinical development and growing demand of innovative solutions in healthcare industry Due to emerging shortage of clinical resources such as lack of disease population, well sound medical infrastructure and trained labor are obstructing the process to initiate trials.
For granular level understanding the Clinical Trials Market is segmented based on Phase, design and Indication, each being provided with Market Size Estimations and Y-o-Y Forecasts. Based on Phases: Introduction Phase I Phase II Phase III Y-o-Y Growth Analysis, By Phases Market Attractiveness Analysis, By Phases Market Share Analysis, By Phases Based on Design: Introduction Interventional trials Observational trials Expanded Access trials Y-o-Y Growth Analysis, By Design Market Attractiveness Analysis, By Design Market Share Analysis, By Design Based on Indications: Introduction Autoimmune Blood disorders Cancer Circulatory CNS Congenital CVS Dermatology Ear Gastrointestinal Genitourinary Infections Mental disorders Metabolic Musculoskeletal Nose Ophthalmology Y-o-Y Growth Analysis, By Indications Market Attractiveness Analysis, By Indications Market Share Analysis, By Indications
Geographically, Middle East and Africa market for Clinical Trials is segmented into Middle East region and Africa region. The Clinical Trials market in the Middle East and Africa region is predicted to grow at the high CAGR. Emerging countries account for the largest share due to growing trend of rising strategic alliances and support from the respective government bodies, joint ventures and acquisitions. Some of the key players that operate in the Middle-East and Africa Clinical Trials Market include Omnicare, Chiltern, ICON Plc, PPD, Charles River, Kendle, Parexel, and Quintles.
Recently the number of newly registered clinical trials has increased, we see an expected growth in Phases I and II studies. Logically, the number of Phase III studies has declined. Along with this move to earlier phase studies, we also see a change in the geographical placement of studies by phase. The biggest growth (of 82%) occurred in Phase I studies, Phase II enlarged by 21% and Phase III reduced 10%. Post-marketing Phase IV studies grown up by 19%.
The Middle-East and Africa Clinical Trials Market report offers wide-range of scope: Regional level analysis that provides an individual perspective of Middle-East and Africa region individually and on a whole Know more about key areas of industry growth via detailed Segment-level analysis on basis of Phase, design and Indication along with market size forecasts and y-o-y estimations Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
For more reports related to the Pharmaceuticals Market:
About Market Data Forecast: Market Data Forecast is one of the prominent market research companies which offers syndicated as well as customized research services to individual or corporate clients. Their syndicated research reports contain Market Sizing and forecasts for 5-year period with a niche level of segmentation providing you with more focused insights whereas the consult research services can fetch the distinctive data requirements at competitive industry costs.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
